Latest filing published 03 Jan 2017 for Advaxis, Inc., €3,101.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory T. Mayes: trading record in brief
This profile gathers the share dealings of Gregory T. Mayes across 4 companies, led by Advaxis, Inc., Imclone Systems Inc/de and Dendreon Corp. The record holds 84 filings, for trades running from 15 February 2008 to 30 December 2016.
In open-market terms, that means 1 purchase worth €802 on one side and 2 sales worth €348k on the other. On balance, insiders were net sellers of €347k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 80 share grants and 1 option exercise.
Most recently, on 3 January 2017, the filings show a share grant worth €3,101 in Advaxis, Inc. The most recent open-market purchase was published on 22 December 2011, 5,435 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gregory T. Mayes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 458 shares@ US$7.161.8% of flowCommon StockSEC:0001493152-17-000064:0
- 119 shares@ US$7.160.5% of flowCommon StockSEC:0001493152-17-000064:1
- 263 shares@ US$8.311.2% of flowCommon StockSEC:0001493152-16-015589:0
- 58 shares@ US$8.310.3% of flowCommon StockSEC:0001493152-16-015589:1
- 270 shares@ US$8.091.1% of flowCommon StockSEC:0001493152-16-014440:0
- 60 shares@ US$8.090.3% of flowCommon StockSEC:0001493152-16-014440:1
- 19,162 shares@ US$8.2383.2% of flowCommon StockSEC:0001493152-16-014281:0
- 204 shares@ US$10.691.1% of flowCommon StockSEC:0001493152-16-013840:0
- 45 shares@ US$10.690.2% of flowCommon StockSEC:0001493152-16-013840:1
- 190 shares@ US$11.531.1% of flowCommon StockSEC:0001493152-16-013047:0
- 42 shares@ US$11.530.2% of flowCommon StockSEC:0001493152-16-013047:1
- 262 shares@ US$8.341.1% of flowCommon StockSEC:0001493152-16-011882:0
- 58 shares@ US$8.340.3% of flowCommon StockSEC:0001493152-16-011882:1
- 405 shares@ US$8.091.7% of flowCommon StockSEC:0001493152-16-011245:0
- 105 shares@ US$8.090.4% of flowCommon StockSEC:0001493152-16-011245:1
- 236 shares@ US$9.261.1% of flowCommon StockSEC:0001493152-16-010480:0
- 52 shares@ US$9.260.2% of flowCommon StockSEC:0001493152-16-010480:1
- 282 shares@ US$7.741.1% of flowCommon StockSEC:0001493152-16-009320:0
- 62 shares@ US$7.740.2% of flowCommon StockSEC:0001493152-16-009320:1
- 242 shares@ US$9.031.1% of flowCommon StockSEC:0001493152-16-008610:0
- 54 shares@ US$9.030.2% of flowCommon StockSEC:0001493152-16-008610:1
- 400 shares@ US$5.461.1% of flowCommon StockSEC:0001493152-16-007756:0
- 88 shares@ US$5.460.3% of flowCommon StockSEC:0001493152-16-007756:1
- 312 sharesCommon StockSEC:0001493152-16-007073:0
- 87 sharesCommon StockSEC:0001493152-16-007073:1
25 of 78 declarations
